Current Members

Astellas logo
Bayer logo
Biogen logo
Boehringer Ingelheim logo
Bristol Myers Squibb logo
Johnson & Johnson logo
Merck Sharp Dohme (MSD) logo
Merck logo
Novartis logo
Pfizer logo
Roche logo

Membership Structure

Membership is currently available to biopharmaceutical, pharmaceutical, and eligible health authority/regulatory organizations. IMPALA Consortium aims to provide each Member with an opportunity to make valuable contributions to the industry. To facilitate this, biopharmaceutical membership begins with Bio Pharma Sponsor Level.

Membership Class Annual Membership Dues
Governing Board Level US $15,000
Bio Pharma Sponsor Level US $7,500
Health Authority Partner* US $0

*The list of eligible organizations may change based on evolving interest and bandwidth. At IMPALA’s current scale, Health Authority Partner Membership will be available to the following organizations: U.S. Food and Drug Administration (FDA), Health Canada, Medicine and Health Products Regulatory Agency (MHRA), European Medicines Agency (EMA), Pharmaceutical Medicines and Device Agency (PMDA), National Medical Products Administration (NMPA), Health Sciences Authority (HSA), SwissMedic, Therapeutic Goods Administration (TGA) and International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH.)

Membership Benefits

  • Make valuable contributions to shift the quality assurance paradigm in the biopharmaceutical industry

  • Connect with experts across the industry

  • Enhance knowledge in areas of interest and expertise through work group projects
  • Access to members-only meetings, resources, materials, and work products prior to public publishing
  • Where relevant, be included in webinars, presentations, and press releases highlighting the work of the consortium
  • Be a part of the movement to accelerate approval and patient access to innovative drugs

Benefits vary based on membership type. 

Join Now

To find out more about IMPALA consortium, the membership process, and opportunities to contribute expertise please contact us at